The global medical rehabilitation robotics market is forecasted to expand at 15.2% CAGR to reach a market valuation of US$ 1.76 Billion by the end of 2033, up from US$ 366.2 Million that was recorded for 2022.
The pediatric rehabilitation robotics is an emerging market. The expansion of rehabilitation services for patients with autism and cerebral palsy to accelerate the market
| Report Attribute | Details |
|---|---|
| Medical Rehabilitation Robotics Market Size (2023) | US$ 428.9 Million |
| Forecasted Market Value (2033) | US$ 1.76 Billion |
| Value CAGR (2023 to 2033) | 15.2% |
| Collective Value Share: Top 5 Countries (2022) | 66.4% |
| Key Market Players | Ekso Bionics Holdings Inc., AlterG, Inc., Bionik Laboratories Corp., Cyberdyne Inc., ReWalk Robotics, Instead Technologies Ltd., Hocoma AG, Fourier Intelligence, Tyromotion Gmbh, Toyota Motor Corporation, BeatBots LLC, Bioxtreme, Rex Bionics Inc., and LEADERS REHAB ROBOT Co. Ltd. |
One of the most desirable and successful applications of the robot in healthcare appears to be rehabilitation. The four steps of a normal rehabilitation session are identifying the patient's condition, defining the rehabilitation goals, organizing and carrying out the treatments, and finally assessing the results.
Robots have the ability to transform and improve this sector by lowering the physical therapist’s burden, allowing less supervision by therapists, and offering more precise tracking of patient development throughout the sessions.
Rehabilitation robotics is designed to support the motion of various sensorimotor functions for mechanical actions including arm, leg, and ankle. These tools aid in accelerating the healing of patients who are dealing with mobility disorders combined with physically weakened bodies.
According to this new medical rehabilitation robotics market survey report by Future Market Insights, the global market has huge growth potential owing to the increased the efficiency of and accessibility to rehabilitation therapy.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for medical rehabilitation robotics expanded at a CAGR of 39.5% during the historic period (2017 to 2022) and reached a market value of US$ 366.2 Million in 2022.
The need for robotic rehabilitation in healthcare is being driven by an increase in the population of people with physical disabilities and a decrease in the number of nurses who are available. The World Health Organization estimates that 15 Million people experience a stroke each year. A third of these individuals continue to experience some form of functional disability, making it challenging for them to regain independence in daily life tasks. As such, incidences are increasing; the demand for the medical rehabilitation robotics is rising.
With advances in materials, increased reliability, control software, and the reduction of sensor and actuator size, automated robotics applications are expected to grow. This will enable design and modeling using mechatronics technology to enhance the health of individuals with disabilities.
The global market is predicted to grow stably, to its current size by the end of 2033.
| Market Statistics | Details |
|---|---|
| Jan - Jun (H1), 2021 (A) | 14.85% |
| Jul - Dec (H2), 2021 (A) | 21.06% |
| Jan - Jun (H1),2022 Projected (P) | 14.71% |
| Jan - Jun (H1),2022 Outlook (O) | 15.53% |
| Jul - Dec (H2), 2022 Outlook (O) | 19.69% |
| Jul - Dec (H2), 2022 Projected (P) | 18.35% |
| Jan - Jun (H1), 2023 Projected (P) | 15.49% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 82↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | 68↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 134 ↑ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | (-)138↓ |
Principal Consultant
Lack of awareness and adoption of rehabilitation facilities
Although the concept of rehabilitation is commonly understood in industrialized economies, it is not widely acknowledged or used in emerging economies. Many patients in developing nations with low and intermediate income levels lack access to rehabilitation services.
Less than 10 skilled practitioners per Million people work in the field of rehabilitation, which is an obstacle to the market's expansion.
Robotics used for rehabilitation services demand significant financial investments, and depending on the type of rehabilitation, their routine maintenance and operations might be rather expensive. Therefore, it is anticipated that the high price of rehabilitation robots will restrain the market's expansion in developing regions.
Patient trust is one of the main barriers to the use of robotics in rehabilitation. For instance, according to a survey conducted by the World Economic Forum, one-third of patients stated they would not trust a robot to regularly clean their teeth. 2/3 of people said they would not trust a robot to perform more complex treatments like root canals.
Robotic rehabilitation for children with physical disabilities could fulfill children’s needs and inspire researchers to develop new devices. Investment in research and development by the leading manufacturers to gain a competitive edge
Most of robotic rehabilitation devices currently available are made for adult patients, whose needs are different from those of pediatric patients. Due to inadequate consideration of pediatric patients' demands, this restricts the gadgets' potential. Research and development of robotic rehabilitation that can meet needs may provide profitable market opportunities.
Whether through collaboration or research contracts with reputable research institutions, leading manufacturers are investing in research initiatives to gain a competitive edge.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The United Stated |
|---|---|
| Market Share (2023) | 44.6% |
| Market Share (2033) | 38.7% |
| BPS Analysis | -590 |
| Country | The United Kingdom |
|---|---|
| Market Share (2023) | 7.1% |
| Market Share (2033) | 5.8% |
| BPS Analysis | -130 |
| Country | Germany |
|---|---|
| Market Share (2023) | 5.7% |
| Market Share (2033) | 4.9% |
| BPS Analysis | -81 |
| Country | Canada |
|---|---|
| Market Share (2023) | 4.8% |
| Market Share (2033) | 3.4% |
| BPS Analysis | -143 |
| Country | China |
|---|---|
| Market Share (2023) | 4.5% |
| Market Share (2033) | 5.6% |
| BPS Analysis | 111 |
The United States is set to hold a share of around 44.6% of the global market in 2023.
People with physical limitations in the area are the drivers driving sales in the medical rehabilitation robots market. For instance, a research in the Journal of Neuro-Engineering and Rehabilitation found that between 249,000 and 363,000 people in the United States have difficulties brought on by spinal cord injuries (SCI) and that 17,730 people suffer a new SCI every year.
Germany is set to hold a share of 5.7% of the global market in 2023.
The region's growing need for medical rehabilitation robots is due to the development of the healthcare sectors. Germany, along with the United Kingdom, Denmark, and Spain, is listed in the TOP-10 of "Countries with the Best Health Care Systems in Europe" according to CEOWorld Magazine.
Japan is set to hold a share of 3.1% of the global market in 2023.
With more than 6,020,000 dementia patients, Japan has already reached the status of a "super-aging society," and with the aid of geriatric rehabilitation procedures, many elderly people with disabilities can live peacefully in their communities. As a result, there is a growing need for medical rehabilitation robotics.
Therapeutics/ assistive products are expected to hold a market share of 74.5% in 2023. The capacity of these devices to help patients move around while gathering sensory data that is processed and customized for patient’s usage to speed up healing is credited with the growth.
The upper extremity segment is predicted to account for 59.0% of the overall market share in the field of extremity during the year 2023. The development of automated robotic assistive devices for patients with impairments and cognitive inequalities is expected to increase as medical prosthesis sales rise.
The limb mobility therapy segment is projected to account for 60.7% of the total market share in the year 2023. The development of structured robotic exoskeleton systems for reducing labor-intensive tasks is expected to boost sales.
The adults are projected to contribute 87.5% revenue share to the global market. This is because older persons with high fall risk were much more likely to report using rehabilitation services than those with low and moderate fall risk. According to a study in NCBI, among older adults, falls are the most common cause of injury, morbidity, and functional impairment. An annual fall affects the health of the public in a substantial way for 30% of persons 65 and over.
The Neurorehabilitation segments predicted to hold more than half of the global value share in 2023. Growing prevalence of neurodegenerative diseases is leading to various behavioral and cognitive function disorders, which in turn boosting the application of rehabilitation robotics for Neurorehabilitation.
Sales in rehabilitation centers accounted for 47.6% of the total market share in 2022 and it is expected to have dominance in the forecast period. Sales in this sector are being driven by growing awareness of rehabilitation treatments that address both the physical and mental components of the disease.
The need for rehabilitation is expected to grow globally due to changes in population health and features, according to the WHO (world health organization). For example, people are living longer, but with more chronic disease and disability.
The market for medical rehabilitation robotics is competitive and has several established companies. Due to the advanced technology acceptance by the patients and the product approvals by the federal agencies of the Department of Health and Human Services, are allowing to compete efficiently. The key market players are promoting the robotic care devices for overseas.
Recent Market Developments
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the medical rehabilitation robotics space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, Asia-Pacific excluding Japan, and the Middle East and Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, Extremity, Therapy, Patient, Application, End User and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The medical rehabilitation robotics market CAGR for 2033 is 15.2%.
The market is estimated to reach US$ 1.76 billion by 2033.
Key medical rehabilitation robotics market players are introducing innovative products.
The market is estimated to secure a valuation of US$ 428.9 million in 2023.
The increasing prevalence of chronic diseases and injuries.
1. Executive Summary | Medical Rehabilitation Robotics Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption /Usage Analysis
4.2. Technology Assessment
4.3. Promotional Strategies, By Key Players
4.4. Regulatory Landscape
4.5. Reimbursement Outlook
4.6. Supply Chain Analysis
4.7. Porter’s Analysis
4.8. PESTEL Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Prevalence of Chronic Disorders
5.2.2. Availability of Treatment
5.2.3. Cost of Treatment
5.2.4. Increasing Product Approvals
5.2.5. Increasing Cases of Physical Disabilities
5.2.6. Mergers and Acquisitions
5.2.7. Regulatory Policies
5.2.8. Advertisements and Endorsements
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Extremity
6.1.3. By Therapy
6.1.4. By Patient
6.1.5. By Application
6.1.6. By End User
6.1.7. By Region
6.2. 2022 Market Scenario
7. Global Market Demand (in Volume Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Volume (Units) Analysis, 2017 to 2022
7.2. Current and Future Market Volume (units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Product, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, by Product, 2023 to 2033
10.3.1. Exoskeleton
10.3.2. Therapeutic/ Assistive
10.4. Market Attractiveness Analysis, by Product
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Extremity
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis, By Extremity, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Extremity, 2023 to 2033
11.3.1. Upper Extremity
11.3.1.1. Arm
11.3.1.2. Wrist
11.3.1.3. Shoulder
11.3.1.4. Elbow
11.3.2. Lower Extremity
11.4. Market Attractiveness Analysis, by Extremity
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Therapy
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis, By Therapy, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Therapy, 2023 to 2033
12.3.1. Limb Mobility
12.3.2. Gait
12.3.3. Sensory
12.4. Market Attractiveness Analysis, by Therapy
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Patient
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Analysis, By Patient, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Patient, 2023 to 2033
13.3.1. Adults
13.3.2. Pediatric
13.4. Market Attractiveness Analysis, by Patient
14. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) Analysis, By Application, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Application, 2023 to 2033
14.3.1. Neurorehabilitation
14.3.2. Physical Rehabilitation
14.3.3. Other
14.4. Market Attractiveness Analysis, by Application
15. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Million) Analysis, By End User, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by End User, 2023 to 2033
15.3.1. Hospitals
15.3.2. Wellness centers
15.3.3. Rehabilitation centers
15.3.4. Others
15.4. Market Attractiveness Analysis, by End User
16. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Region, 2017 to 2022
16.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, By Region, 2023 to 2033
16.3.1. North America
16.3.2. Latin America
16.3.3. Europe
16.3.4. East Asia
16.3.5. South Asia
16.3.6. Oceania
16.3.7. Middle East and Africa (MEA)
16.4. Market Attractiveness Analysis, by Region
17. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. The USA
17.3.1.2. Canada
17.3.2. By Product
17.3.3. By Extremity
17.3.4. By Therapy
17.3.5. By Patient
17.3.6. By Application
17.3.7. By End user
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Extremity
17.4.4. By Therapy
17.4.5. By Patient
17.4.6. By Application
17.4.7. By End user
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. USA Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Extremity
17.8.1.2.3. By Therapy
17.8.1.2.4. By Patient
17.8.1.2.5. By Application
17.8.1.2.6. By End User
17.8.2. Canada Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Extremity
17.8.2.2.3. By Therapy
17.8.2.2.4. By Patient
17.8.2.2.5. By Application
17.8.2.2.6. By End User
18. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Mexico
18.3.1.2. Brazil
18.3.1.3. Argentina
18.3.1.4. Rest of Latin America
18.3.2. By Product
18.3.3. By Extremity
18.3.4. By Therapy
18.3.5. By Patient
18.3.6. By Application
18.3.7. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Extremity
18.4.4. By Therapy
18.4.5. By Patient
18.4.6. By Application
18.4.7. By End User
18.5. Market Trends
18.6. Key Market Participants – Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. Mexico Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Extremity
18.8.1.2.3. By Therapy
18.8.1.2.4. By Patient
18.8.1.2.5. By Application
18.8.1.2.6. By End User
18.8.2. Brazil Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Extremity
18.8.2.2.3. By Therapy
18.8.2.2.4. By Patient
18.8.2.2.5. By Application
18.8.2.2.6. By End User
18.8.3. Argentina Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Extremity
18.8.3.2.3. By Therapy
18.8.3.2.4. By Patient
18.8.3.2.5. By Application
18.8.3.2.6. By End User
19. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Germany
19.3.1.2. Italy
19.3.1.3. France
19.3.1.4. United Kingdom
19.3.1.5. Spain
19.3.1.6. BENELUX
19.3.1.7. Russia
19.3.1.8. Rest of Europe
19.3.2. By Product
19.3.3. By Extremity
19.3.4. By Therapy
19.3.5. By Patient
19.3.6. By Application
19.3.7. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Extremity
19.4.4. By Therapy
19.4.5. By Patient
19.4.6. By Application
19.4.7. By End User
19.5. Market Trends
19.6. Key Market Participants – Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. Germany Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast, by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Extremity
19.8.1.2.3. By Therapy
19.8.1.2.4. By Patient
19.8.1.2.5. By Application
19.8.1.2.6. By End User
19.8.2. Italy Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast, by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Extremity
19.8.2.2.3. By Therapy
19.8.2.2.4. By Patient
19.8.2.2.5. By Application
19.8.2.2.6. By End User
19.8.3. France Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast, by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Extremity
19.8.3.2.3. By Therapy
19.8.3.2.4. By Patient
19.8.3.2.5. By Application
19.8.3.2.6. By End User
19.8.4. United Kingdom Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast, by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Extremity
19.8.4.2.3. By Therapy
19.8.4.2.4. By Patient
19.8.4.2.5. By Application
19.8.4.2.6. By End User
19.8.5. Spain Market Analysis
19.8.5.1. Introduction
19.8.5.2. Market Analysis and Forecast, by Market Taxonomy
19.8.5.2.1. By Product
19.8.5.2.2. By Extremity
19.8.5.2.3. By Therapy
19.8.5.2.4. By Patient
19.8.5.2.5. By Application
19.8.5.2.6. By End User
19.8.6. BENELUX Market Analysis
19.8.6.1. Introduction
19.8.6.2. Market Analysis and Forecast, by Market Taxonomy
19.8.6.2.1. By Product
19.8.6.2.2. By Extremity
19.8.6.2.3. By Therapy
19.8.6.2.4. By Patient
19.8.6.2.5. By Application
19.8.6.2.6. By End User
19.8.7. Russia Market Analysis
19.8.7.1. Introduction
19.8.7.2. Market Analysis and Forecast, by Market Taxonomy
19.8.7.2.1. By Product
19.8.7.2.2. By Extremity
19.8.7.2.3. By Therapy
19.8.7.2.4. By Patient
19.8.7.2.5. By Application
19.8.7.2.6. By End User
20. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Patient (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022
20.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. China
20.3.1.2. Japan
20.3.1.3. South Korea
20.3.2. By Product
20.3.3. By Extremity
20.3.4. By Therapy
20.3.5. By Patient
20.3.6. By Application
20.3.7. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Product
20.4.2. By Extremity
20.4.3. By Therapy
20.4.4. By Patient
20.4.5. By Application
20.4.6. By End User
20.5. Market Trends
20.6. Key Market Participants – Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country Level Analysis & Forecast
20.8.1. China Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast, by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Extremity
20.8.1.2.3. By Therapy
20.8.1.2.4. By Patient
20.8.1.2.5. By Application
20.8.1.2.6. By End User
20.8.2. Japan Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast, by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Extremity
20.8.2.2.3. By Therapy
20.8.2.2.4. By Patient
20.8.2.2.5. By Application
20.8.2.2.6. By End User
20.8.3. South Korea Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast, by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Extremity
20.8.3.2.3. By Therapy
20.8.3.2.4. By Patient
20.8.3.2.5. By Application
20.8.3.2.6. By End User
21. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
21.1. Introduction
21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022
21.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
21.3.1. By Country
21.3.1.1. India
21.3.1.2. Indonesia
21.3.1.3. Malaysia
21.3.1.4. Thailand
21.3.1.5. Rest of South Asia
21.3.2. By Product
21.3.3. By Extremity
21.3.4. By Therapy
21.3.5. By Patient
21.3.6. By Application
21.3.7. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By Extremity
21.4.4. By Therapy
21.4.5. By Patient
21.4.6. By Application
21.4.7. By End User
21.5. Market Trends
21.6. Key Market Participants – Intensity Mapping
21.7. Drivers and Restraints - Impact Analysis
21.8. Country Level Analysis & Forecast
21.8.1. India Market Analysis
21.8.1.1. Introduction
21.8.1.2. Market Analysis and Forecast, by Market Taxonomy
21.8.1.2.1. By Product
21.8.1.2.2. By Extremity
21.8.1.2.3. By Therapy
21.8.1.2.4. By Patient
21.8.1.2.5. By Application
21.8.1.2.6. By End User
21.8.2. Indonesia Market Analysis
21.8.2.1. Introduction
21.8.2.2. Market Analysis and Forecast, by Market Taxonomy
21.8.2.2.1. By Product
21.8.2.2.2. By Extremity
21.8.2.2.3. By Therapy
21.8.2.2.4. By Patient
21.8.2.2.5. By Application
21.8.2.2.6. By End User
21.8.3. Malaysia Market Analysis
21.8.3.1. Introduction
21.8.3.2. Market Analysis and Forecast, by Market Taxonomy
21.8.3.2.1. By Product
21.8.3.2.2. By Extremity
21.8.3.2.3. By Therapy
21.8.3.2.4. By Patient
21.8.3.2.5. By Application
21.8.3.2.6. By End User
21.8.4. Thailand Market Analysis
21.8.4.1. Introduction
21.8.4.2. Market Analysis and Forecast, by Market Taxonomy
21.8.4.2.1. By Product
21.8.4.2.2. By Extremity
21.8.4.2.3. By Therapy
21.8.4.2.4. By Patient
21.8.4.2.5. By Application
21.8.4.2.6. By End User
22. Oceania Market 2012 to 2022 and Forecast 2022-2033
22.1. Introduction
22.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022
22.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
22.3.1. By Country
22.3.1.1. Australia
22.3.1.2. New Zealand
22.3.2. By Product
22.3.3. By Extremity
22.3.4. By Therapy
22.3.5. By Patient
22.3.6. By Application
22.3.7. By End User
22.4. Market Attractiveness Analysis
22.4.1. By Country
22.4.2. By Product
22.4.3. By Extremity
22.4.4. By Therapy
22.4.5. By Patient
22.4.6. By Application
22.4.7. By End User
22.5. Market Trends
22.6. Key Market Participants – Intensity Mapping
22.7. Drivers and Restraints - Impact Analysis
22.8. Country Level Analysis & Forecast
22.8.1. Australia Market Analysis
22.8.1.1. Introduction
22.8.1.2. Market Analysis and Forecast, by Market Taxonomy
22.8.1.2.1. By Product
22.8.1.2.2. By Extremity
22.8.1.2.3. By Therapy
22.8.1.2.4. By Patient
22.8.1.2.5. By Application
22.8.1.2.6. By End User
22.8.2. New Zealand Market Analysis
22.8.2.1. Introduction
22.8.2.2. Market Analysis and Forecast, by Market Taxonomy
22.8.2.2.1. By Product
22.8.2.2.2. By Extremity
22.8.2.2.3. By Therapy
22.8.2.2.4. By Patient
22.8.2.2.5. By Application
22.8.2.2.6. By End User
23. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033
23.1. Introduction
23.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022
23.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
23.3.1. By Country
23.3.1.1. GCC Countries
23.3.1.2. Türkiye
23.3.1.3. South Africa
23.3.1.4. North Africa
23.3.1.5. Rest of Middle East and Africa
23.3.2. By Product
23.3.3. By Extremity
23.3.4. By Therapy
23.3.5. By Patient
23.3.6. By Application
23.3.7. By End User
23.4. Market Attractiveness Analysis
23.4.1. By Product
23.4.2. By Extremity
23.4.3. By Therapy
23.4.4. By Patient
23.4.5. By Application
23.4.6. By End User
23.5. Market Trends
23.6. Key Market Participants – Intensity Mapping
23.7. Drivers and Restraints - Impact Analysis
23.8. Country Level Analysis & Forecast
23.8.1. GCC Countries Market Analysis
23.8.1.1. Introduction
23.8.1.2. Market Analysis and Forecast, by Market Taxonomy
23.8.1.2.1. By Product
23.8.1.2.2. By Extremity
23.8.1.2.3. By Therapy
23.8.1.2.4. By Patient
23.8.1.2.5. By Application
23.8.1.2.6. By End User
23.8.2. Türkiye Market Analysis
23.8.2.1. Introduction
23.8.2.2. Market Analysis and Forecast, by Market Taxonomy
23.8.2.2.1. By Product
23.8.2.2.2. By Extremity
23.8.2.2.3. By Therapy
23.8.2.2.4. By Patient
23.8.2.2.5. By Application
23.8.2.2.6. By End User
23.8.3. South Africa Market Analysis
23.8.3.1. Introduction
23.8.3.2. Market Analysis and Forecast, by Market Taxonomy
23.8.3.2.1. By Product
23.8.3.2.2. By Extremity
23.8.3.2.3. By Therapy
23.8.3.2.4. By Patient
23.8.3.2.5. By Application
23.8.3.2.6. By End User
23.8.4. North Africa Market Analysis
23.8.4.1. Introduction
23.8.4.2. Market Analysis and Forecast, by Market Taxonomy
23.8.4.2.1. By Product
23.8.4.2.2. By Extremity
23.8.4.2.3. By Therapy
23.8.4.2.4. By Patient
23.8.4.2.5. By Application
23.8.4.2.6. By End User
24. Market Structure Analysis
24.1. Market Analysis, by Tier of Companies
24.2. Market Share Analysis of Top Players
24.3. Market Presence Analysis
25. Competition Analysis
25.1. Competition Dashboard
25.2. Competition Benchmarking
25.3. Competition Deep Dive
25.3.1. Ekso Bionics Holdings Inc.
25.3.1.1. Overview
25.3.1.2. Product Portfolio
25.3.1.3. Sales Footprint
25.3.1.4. Key Financials
25.3.1.5. SWOT Analysis
25.3.1.6. Strategy Overview
25.3.1.6.1. Marketing Strategy
25.3.1.6.2. Product Strategy
25.3.1.6.3. Channel Strategy
25.3.2. AlterG, Inc.
25.3.2.1. Overview
25.3.2.2. Product Portfolio
25.3.2.3. Sales Footprint
25.3.2.4. Key Financials
25.3.2.5. SWOT Analysis
25.3.2.6. Strategy Overview
25.3.2.6.1. Marketing Strategy
25.3.2.6.2. Product Strategy
25.3.2.6.3. Channel Strategy
25.3.3. Bionik Laboratories Corp.
25.3.3.1. Overview
25.3.3.2. Product Portfolio
25.3.3.3. Sales Footprint
25.3.3.4. Key Financials
25.3.3.5. SWOT Analysis
25.3.3.6. Strategy Overview
25.3.3.6.1. Marketing Strategy
25.3.3.6.2. Product Strategy
25.3.3.6.3. Channel Strategy
25.3.4. Cyberdyne Inc.
25.3.4.1. Overview
25.3.4.2. Product Portfolio
25.3.4.3. Sales Footprint
25.3.4.4. Key Financials
25.3.4.5. SWOT Analysis
25.3.4.6. Strategy Overview
25.3.4.6.1. Marketing Strategy
25.3.4.6.2. Product Strategy
25.3.4.6.3. Channel Strategy
25.3.5. ReWalk Robotics
25.3.5.1. Overview
25.3.5.2. Product Portfolio
25.3.5.3. Sales Footprint
25.3.5.4. Key Financials
25.3.5.5. SWOT Analysis
25.3.5.6. Strategy Overview
25.3.5.6.1. Marketing Strategy
25.3.5.6.2. Product Strategy
25.3.5.6.3. Channel Strategy
25.3.6. Instead Technologies Ltd.
25.3.6.1. Overview
25.3.6.2. Product Portfolio
25.3.6.3. Sales Footprint
25.3.6.4. Key Financials
25.3.6.5. SWOT Analysis
25.3.6.6. Strategy Overview
25.3.6.6.1. Marketing Strategy
25.3.6.6.2. Product Strategy
25.3.6.6.3. Channel Strategy
25.3.7. Bioxtreme
25.3.7.1. Overview
25.3.7.2. Product Portfolio
25.3.7.3. Sales Footprint
25.3.7.4. Key Financials
25.3.7.5. SWOT Analysis
25.3.7.6. Strategy Overview
25.3.7.6.1. Marketing Strategy
25.3.7.6.2. Product Strategy
25.3.7.6.3. Channel Strategy
25.3.8. Rex Bionics Ltd
25.3.8.1. Overview
25.3.8.2. Product Portfolio
25.3.8.3. Sales Footprint
25.3.8.4. Key Financials
25.3.8.5. SWOT Analysis
25.3.8.6. Strategy Overview
25.3.8.6.1. Marketing Strategy
25.3.8.6.2. Product Strategy
25.3.8.6.3. Channel Strategy
25.3.9. Hocoma AG
25.3.9.1. Overview
25.3.9.2. Product Portfolio
25.3.9.3. Sales Footprint
25.3.9.4. Key Financials
25.3.9.5. SWOT Analysis
25.3.9.6. Strategy Overview
25.3.9.6.1. Marketing Strategy
25.3.9.6.2. Product Strategy
25.3.9.6.3. Channel Strategy
25.3.10. Fourier Intelligence
25.3.10.1. Overview
25.3.10.2. Product Portfolio
25.3.10.3. Sales Footprint
25.3.10.4. Key Financials
25.3.10.5. SWOT Analysis
25.3.10.6. Strategy Overview
25.3.10.6.1. Marketing Strategy
25.3.10.6.2. Product Strategy
25.3.10.6.3. Channel Strategy
25.3.11. Tyromotion Gmbh
25.3.11.1. Overview
25.3.11.2. Product Portfolio
25.3.11.3. Sales Footprint
25.3.11.4. Key Financials
25.3.11.5. SWOT Analysis
25.3.11.6. Strategy Overview
25.3.11.6.1. Marketing Strategy
25.3.11.6.2. Product Strategy
25.3.11.6.3. Channel Strategy
25.3.12. Toyota Motor Corporation
25.3.12.1. Overview
25.3.12.2. Product Portfolio
25.3.12.3. Sales Footprint
25.3.12.4. Key Financials
25.3.12.5. SWOT Analysis
25.3.12.6. Strategy Overview
25.3.12.6.1. Marketing Strategy
25.3.12.6.2. Product Strategy
25.3.12.6.3. Channel Strategy
25.3.13. BeatBots LLC
25.3.13.1. Overview
25.3.13.2. Product Portfolio
25.3.13.3. Sales Footprint
25.3.13.4. Key Financials
25.3.13.5. SWOT Analysis
25.3.13.6. Strategy Overview
25.3.13.6.1. Marketing Strategy
25.3.13.6.2. Product Strategy
25.3.13.6.3. Channel Strategy
25.3.14. LEADERS REHAB ROBOT Co. Ltd.
25.3.14.1. Overview
25.3.14.2. Product Portfolio
25.3.14.3. Sales Footprint
25.3.14.4. Key Financials
25.3.14.5. SWOT Analysis
25.3.14.6. Strategy Overview
25.3.14.6.1. Marketing Strategy
25.3.14.6.2. Product Strategy
25.3.14.6.3. Channel Strategy
26. Assumptions and Acronyms Used
27. Research Methodology
Explore Healthcare Insights
View Reports
Medical Rehabilitation Robotics Market
